Lithium (low-dose lithium orotate)
Trace mineral found in food and water; low brain lithium is linked to Alzheimer's amyloid, tau, and neuroinflammation.
Summary
Debbie covers lithium as a naturally occurring trace mineral, distinct from high-dose prescription lithium carbonate. Her posts cite population studies linking higher drinking-water lithium to lower dementia rates, small clinical trials of microdoses in Alzheimer's patients, and a 2025 Nature study finding lithium was the only trace metal lower in MCI/Alzheimer's brains, with mouse work showing lithium deficiency increased amyloid and tau and low-dose lithium orotate reduced age-related microglial activation. Mechanistically she ties lithium to GSK-3β inhibition, circadian rhythm, anti-inflammatory effects, and (in a cell study) reduced senescence-associated cytokines. She notes the ideal dose is unknown and that studies mainly show little benefit for reversing Alzheimer's after diagnosis.
"Personally, I'm taking 5 mg/day for Alzheimer's prevention, but I admit that I don't remember to take it every day." (Not listed in her Jan 2026 stack post.)From Brain energy changes in Alzheimer's connect to the benefits of low-dose lithium
The evidence
-
Human trial
A 2015 review of three randomized placebo-controlled trials in Alzheimer's patients reported that lithium significantly decreased cognitive decline compared with placebo.
Read the study Discussed in Lithium and Aging (draft) -
Human obs.
A nationwide Danish study (73,000+ dementia patients, 733,000+ controls) found lower dementia rates in people with naturally higher lithium in their drinking water.
Read the study Discussed in Lithium and Aging (draft) -
Human obs.
In human brain tissue, lithium was the only one of 27 trace metals that differed in MCI and Alzheimer's, being lower in plaque-free prefrontal cortex and concentrated in amyloid plaques, while blood levels were similar.
-
Animal
In mice, a nearly lithium-free diet increased amyloid-beta deposition, caused a 3- to 4-fold increase in tau tangles, and impaired memory; low-dose lithium orotate from middle age nearly prevented age-related microglial activation and restored amyloid-beta clearance.
-
Animal
In Alzheimer's model mice, lithium chloride restored clearance of soluble beta-amyloid to normal levels but did not affect amyloid already formed into plaque.
Read the study Discussed in Lithium and Aging (draft) -
Cell
In a cell study, low concentrations of lithium decreased senescence-associated inflammatory cytokines, including IL-6, acting via GSK3B inhibition.
Doses used in studies
Amounts reported in the research, not dosing recommendations.
| Dose | Context |
|---|---|
| 300 μg to 30 mg lithium carbonate (about 57 μg to 5 mg elemental lithium) | Microdoses used in Alzheimer's clinical trials |
| 300 μg to 300 mg | Range of lithium doses in Alzheimer's studies |
| 5–20 mg (typical 120 mg lithium orotate ≈ 5 mg elemental lithium) | Available lithium orotate supplement doses |
| up to about 3 mg/day; provisional RDA 1 mg/day | Estimated natural intake from food and water |
| 900–1200 mg/day lithium carbonate (about 170 mg elemental lithium at 900 mg) | Prescription dosing for bipolar disorder, for comparison |
| 1–5 mg lithium orotate | Her view of a possible range until large clinical trials define the sweet spot |
Cautions
- At prescription levels, plasma lithium above 1.2 mM causes nausea, diarrhea, and tremors; other high-dose effects include thirst, increased urination, weight gain, mental dullness, and increased risk of kidney problems and hypothyroidism.
- One case report of nausea and mild tremor in a teenager who took 18 tablets of a 100 mg lithium orotate supplement.
- A 2021 animal toxicology study of lithium orotate found no genotoxic effects and no organ damage, with no observed adverse effects up to 400 mg/kg/day.
- Anecdotal reports that lithium orotate may cause tiredness or daytime sleepiness; a holistic doctor suggests taking it before bed.
- Talk with a doctor before supplementing, especially if on medications or pregnant or nursing.
- Negative effects in bipolar treatment are seen at high doses (e.g., 300–600+ mg), suggesting a likely wide safety range for low doses.